RAPT Therapeutics (RAPT) Appoints Lori Lyons-Williams to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to RAPT Therapeutics (RAPT) Appoints Lori Lyons-Williams to its Board

RAPT Therapeutics Appoints Industry Veteran Lori Lyons-Williams to its Board of Directors

November 9, 2021 4:01 PM EST

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced the appointment of Lori Lyons-Williams, a 20-year industry veteran, to its Board of Directors.

We are very excited to welcome Lori to RAPTs board of directors, said Brian Wong, M.D., Ph.D., President and CEO of RAPT Therapeutics. Her strong track record of driving strategic and commercial... More